Brainstorm Cell Therapeutics Inc (OTCPK:BCLI)
$ 0.99 -0.090 (-8.33%) Market Cap: 10.93 Mil Enterprise Value: 12.40 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 28/100

Brainstorm Cell Therapeutics Inc (BCLI) Transcripts

  • 1